Role of aripiprazole in treatment-resistant schizophrenia

QR Code

Role of aripiprazole in treatment-resistant schizophrenia

Nilufar Mossaheb,1 Rainer M Kaufmann21Department of Child and Adolescent Psychiatry, 2Department of Psychiatry and Psychotherapy, Medical University, Vienna, AustriaAbstract: About one third of patients with schizophrenia respond unsatisfactorily to antipsychotic treatment and are termed &ld...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Mossaheb N, Kaufmann RM
Format:	article
Langue:	EN
Publié:	Dove Medical Press 2012
Sujets:	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Accès en ligne:	https://doaj.org/article/7b5f76cab93d41eca3e493dda4e3b922
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Aripiprazole-associated tic in a schizophrenia patient
par: Guo X, et autres
Publié: (2015)

Schizophrenia relapse and the clinical usefulness of once-monthly aripiprazole depot injection
par: Wang SM, et autres
Publié: (2014)

Antipsychotic treatments for the elderly: efficacy and safety of aripiprazole
par: Izchak Kohen, et autres
Publié: (2010)

Pharmacotherapy for treatment-resistant schizophrenia
par: Meghan E Mcilwain, et autres
Publié: (2011)

Adjunctive treatment with aripiprazole for risperidone-induced hyperprolactinemia
par: Ranjbar F, et autres
Publié: (2015)

Augmentation treatment in major depressive disorder: focus on aripiprazole
par: J Craig Nelson, et autres
Publié: (2008)

Efficacy and safety of aripiprazole once-monthly in obese and nonobese patients with schizophrenia: a post hoc analysis
par: De Hert M, et autres
Publié: (2015)

Aripiprazole for the management of schizophrenia in the Japanese population: a systematic review and meta-analysis of randomized controlled trials
par: Kishi T, et autres
Publié: (2015)

Role of sublingual asenapine in treatment of schizophrenia
par: Citrome L
Publié: (2011)

Efficacy and tolerability of aripiprazole once monthly for schizophrenia: a systematic review and meta-analysis of randomized controlled trials
par: Oya K, et autres
Publié: (2015)

Aripiprazole in the treatment of Huntington&rsquo;s disease: a case series
par: Andrea Ciammola, et autres
Publié: (2008)

Aripiprazole for the maintenance treatment of bipolar disorder: a review of available evidence
par: McIntyre R, et autres
Publié: (2011)

An economic evaluation of aripiprazole vs olanzapine adapted to the Italian setting using outcomes of metabolic syndrome and risk for diabetes in patients with schizophrenia
par: Giorgio L Colombo, et autres
Publié: (2008)

Treatment and prevention of mania in bipolar&nbsp;I disorder: focus on aripiprazole
par: David J Muzina
Publié: (2009)

Worsened hypertension control induced by aripiprazole
par: Yasui-Furukori N, et autres
Publié: (2013)

Effects of switching from olanzapine to aripiprazole on the metabolic profiles of patients with schizophrenia and metabolic syndrome: a double-blind, randomized, open-label study
par: Wani RA, et autres
Publié: (2015)

Aripiprazole: from pharmacological profile to clinical use
par: Di Sciascio G, et autres
Publié: (2015)

Effects of switching from olanzapine to aripiprazole on the metabolic profiles of patients with schizophrenia and metabolic syndrome: a double-blind, randomized, open-label study [Corrigendum]
par: Wani RA, et autres
Publié: (2015)

Influence of 5-HT1A and 5-HTTLPR genetic variants on the schizophrenia symptoms and occurrence of treatment-resistant schizophrenia
par: Terzić T, et autres
Publié: (2015)

Profile of blonanserin for the treatment of schizophrenia
par: Tenjin T, et autres
Publié: (2013)

Not all partial dopamine D2 receptor agonists are the same in treating schizophrenia. Exploring the effects of bifeprunox and aripiprazole using a computer model of a primate striatal dopaminergic synapse
par: Athan Spiros, et autres
Publié: (2010)

Emerging role of sertindole in the management of schizophrenia
par: Stephanie L Cincotta, et autres
Publié: (2010)

Neural correlates of delusional infestation responding to aripiprazole monotherapy: a case report
par: Ponson L, et autres
Publié: (2015)

Profile of minocycline and its potential in the treatment of schizophrenia
par: Zhang L, et autres
Publié: (2014)

Towards a framework for treatment effectiveness in schizophrenia
par: Juckel G, et autres
Publié: (2014)

Atypical antipsychotics in the treatment of early-onset schizophrenia
par: Hrdlicka M, et autres
Publié: (2015)

Augmentation with antidepressants in schizophrenia treatment: benefit or risk
par: Mao YM, et autres
Publié: (2015)

Once-monthly paliperidone injection for the treatment of schizophrenia
par: Delia Bishara
Publié: (2010)

Erratum:&nbsp;An economic evaluation of aripiprazole vs olanzapine adapted to the Italian setting using outcomes of metabolic syndrome and risk for diabetes in patients with schizophrenia. Neuropsychiatr Dis Treat, 4: 967&ndash;976
par: Colombo GL, et autres
Publié: (2009)

A randomized trial of aripiprazole vs blonanserin for the treatment of acute schizophrenia and related disorders
par: Kishi T, et autres
Publié: (2016)

Yokukansan and its ingredients as possible treatment options for schizophrenia
par: Yu CH, et autres
Publié: (2014)

Measurement of treatment adherence with antipsychotic agents in patients with schizophrenia
par: Xinhua&nbsp;S Ren, et autres
Publié: (2009)

The role of family therapy in the management of schizophrenia: challenges and solutions
par: Caqueo-Urízar A, et autres
Publié: (2015)

Tobacco smoking in treatment-resistant schizophrenia patients is associated with impaired cognitive functioning, more severe negative symptoms, and poorer social adjustment
par: Iasevoli F, et autres
Publié: (2013)

Review of risperidone for the treatment of pediatric and adolescent bipolar disorder and schizophrenia
par: Jeffrey R Bishop, et autres
Publié: (2008)

Long-term safety and tolerability of open-label aripiprazole augmentation of antidepressant therapy in major depressive disorder
par: Berman R, et autres
Publié: (2011)

Dilemma of prescribing aripiprazole under the Taiwan health insurance program: a descriptive study
par: Hsu YC, et autres
Publié: (2015)

Current approaches to treatments for schizophrenia spectrum disorders, part I: an overview and medical treatments
par: Chien WT, et autres
Publié: (2013)

An open-label study of algorithm-based treatment versus treatment-as-usual for patients with schizophrenia
par: Hirano J, et autres
Publié: (2013)

Strategies to improve medication adherence in patients with schizophrenia: the role of support services
par: El-Mallakh P, et autres
Publié: (2015)